SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-11-073714
Filing Date
2011-08-05
Accepted
2011-08-05 16:34:07
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q f59224e10vq.htm 10-Q 352935
2 EX-31.1 f59224exv31w1.htm EX-31.1 7987
3 EX-31.2 f59224exv31w2.htm EX-31.2 8256
4 EX-32.1 f59224exv32w1.htm EX-32.1 4891
  Complete submission text file 0000950123-11-073714.txt   2502615

Data Files

Seq Description Document Type Size
5 EX-101 INSTANCE DOCUMENT nktr-20110630.xml EX-101.INS 350899
6 EX-101 SCHEMA DOCUMENT nktr-20110630.xsd EX-101.SCH 33729
7 EX-101 CALCULATION LINKBASE DOCUMENT nktr-20110630_cal.xml EX-101.CAL 46836
8 EX-101 LABELS LINKBASE DOCUMENT nktr-20110630_lab.xml EX-101.LAB 214763
9 EX-101 PRESENTATION LINKBASE DOCUMENT nktr-20110630_pre.xml EX-101.PRE 148269
10 EX-101 DEFINITION LINKBASE DOCUMENT nktr-20110630_def.xml EX-101.DEF 63031
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24006 | Film No.: 111014623
SIC: 2834 Pharmaceutical Preparations